Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2015.06.042PMID 26192147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R: A language and environment for statistical computing.

  2014cited by this paper
• TIPS: 25 years later.

  2013cited by this paper
• Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature

  2011cited by this paper
• Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial

  2010cited by this paper
• Early use of TIPS in patients with cirrhosis and variceal bleeding.

  2010cited by this paper
• TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update

  2010cited by this paper
• A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.

  2007cited by this paper
• Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

  2007cited by this paper
• TIPS versus paracentesis for cirrhotic patients with refractory ascites.

  2006cited by this paper
• TIPS versus paracentesis for cirrhotic patients with refractory ascites.

  2006cited by this paper
• Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding.

  2005cited by this paper
• Treatment of Refractory Ascites Using Transjugular Intrahepatic Portosystemic Shunt (TIPS) (A Caution)

  2004cited by this paper
• Pathogenesis and pathophysiology of hepatorenal syndrome – is there scope for prevention?

  2004cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2004cited by this paper
• The North American Study for the Treatment of Refractory Ascites.

  2003cited by this paper
• Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.

  2003cited by this paper
• Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

  2002cited by this paper
• Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients

  2001cited by this paper
• Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites

  2001cited by this paper
• A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.

  2000cited by this paper
• Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta‐analysis

  1999cited by this paper
• Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

  1998cited by this paper
• Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

  1997cited by this paper
• Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial

  1996cited by this paper
• Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.

  1996cited by this paper
• Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study

  1994cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper

• Association Between Transjugular Intrahepatic Shunt (TIPS) and Waitlist Outcomes in Simultaneous Liver Kidney (SLK) Transplant Candidates

  2025cites this paper
• Association Between Older Age and TIPS-Related Hospitalization Following Shunt Placement

  2025cites this paper
• The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease

  2025cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study

  2024influential citation
• Radiological and Surgical Treatments of Portal Hypertension.

  2024cites this paper
• Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?

  2024cites this paper
• Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide

  2024cites this paper
• Outcomes of Simultaneous Liver–Kidney Transplant Recipients According to Pre-Transplant Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the United States

  2024cites this paper
• Seguridad de la derivación portosistémica intrahepática transyugular en pacientes en lista de espera para recibir un trasplante hepático. Riesgos y beneficios

  2023cites this paper
• Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt

  2023cites this paper
• Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

  2023cites this paper
• Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension

  2023cites this paper
• Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding

  2023cites this paper
• Transjugular intrahepatic portosystemic shunt safety in patients on the liver transplantation waiting list. Risks and benefits.

  2023cites this paper
• Sarcopenia of Cirrhosis and the Therapeutic Potential of Transjugular Intrahepatic Portosystemic Shunt Creation

  2022cites this paper
• FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts

  2022cites this paper
• A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS ‐ Modified TIPS Score

  2022cites this paper
• Midodrine and the Ladder of Evidence to Climb.

  2021cites this paper
• Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin

  2021cites this paper
• Use of Cone-Beam Computed Tomography (CBCT) for Targeting the Portal Vein in Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures: Comparison of Low-Dose with Standard-Dose CBCT

  2021cites this paper
• Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era—An ALTA Group Study

  2021cites this paper
• Transjugular Intrahepatic Portosystemic Shunt and Locoregional Therapies in Patients Undergoing Orthotopic Liver Transplantation: A Protocol for a Retrospective, Linked United Network for Organ Sharing Cohort

  2021cites this paper
• The association between character of portal blood flow and post-TIPS incidence of hepatic encephalopathy

  2020cites this paper
• The role of interventional radiology in the pre-liver transplant patient

  2020cites this paper
• Epidemiology of Hepatic Encephalopathy.

  2020cites this paper
• Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.

  2020cites this paper
• Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.

  2020cites this paper
• Advances in minimally invasive treatment of portal hypertension

  2019cites this paper
• Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.

  2019cites this paper
• Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.

  2019cites this paper
• Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft.

  2019cites this paper
• Management of portal hypertension before and after liver transplantation

  2018influential citation
• Influence of spontaneous splenorenal shunts on clinical outcomes in decompensated cirrhosis and after liver transplantation

  2018cites this paper
• Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

  2018cites this paper
• Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.

  2018cites this paper
• KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

  2018cites this paper
• Comparison of MELD and Child- Pugh Score for the Prediction of Survival in Portal Hypertension Undergoing Transjugular Intrahepatic Portosystemic Shunt

  2017cites this paper
• The role of TIPS in the management of liver transplant candidates

  2017cites this paper
• Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database

  2017cites this paper
• Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts

  2017cites this paper
• Current management of refractory ascites in patients with cirrhosis

  2017cites this paper
• Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

  2017cites this paper
• Branched‐chain amino acid‐enriched nutrient increases blood platelet count in patients after endoscopic injection sclerotherapy

  2016cites this paper
• Toll-like receptor 9 modifies intestinal serotonergic system.

  2016cites this paper
• Die Bedeutung der TIPS-Implantation im Management von Patienten auf der Lebertransplantationswarteliste // Impact of TIPS implantation in the management of patients on transplatation waiting-list

  2016cites this paper
• Outcomes of liver transplantation in patients with hepatorenal syndrome.

  2016cites this paper
• Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt.

  2016cites this paper
• Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.

  2016cites this paper
• World Journal of Hepatology

  year unknowncites this paper